Cypherpunk Secures $58.9 Million in Post-IPO Financing on November 12, 2025

According to media reports, Cypherpunk, a publicly listed company specializing in privacy and user autonomy, completed a $58.9 million post-IPO financing round on November 12, 2025. Winklevoss Capital served as the sole investor in this round. Following this transaction, Cypherpunk’s total financing has reached $58.9 million.Cypherpunk, formerly known as Leap Therapeutics—a biotechnology company—has rebranded to focus on privacy protection and user autonomy. This latest funding round demonstrates strong market recognition and support for privacy protection technologies. As global privacy regulations become increasingly stringent and user concerns about data security continue to rise, the substantial capital raised is expected to further strengthen Cypherpunk’s competitive position in the privacy protection sector. The company also plans significant acquisitions to expand its business scope and reinforce its industry leadership.